Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A28314 | 15708540 | Clin Biochem | Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. | 2005 | Details |
A28315 | 15706422 | Oncol Rep | CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients. | 2005 | Details |
A28318 | 15700216 | Z Gastroenterol | The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic. | 2005 | Details |
A28319 | 15696851 | Scand J Gastroenterol Suppl | Non-alcoholic fatty liver disease: a brief review. | 2004 | Details |
A28321 | 15690483 | Hepatology | Chronological development of elevated aminotransferases in a nonalcoholic population. | 2005 | Details |
A28325 | 15670668 | Alcohol | Mechanisms of non-alcoholic steatohepatitis. | 2004 | Details |
A28328 | 15641471 | Gac Med Mex | [The metabolic syndrome: a concept in evolution]. | 2005 | Details |
A28332 | 15625647 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease: a review of current understanding and future impact. | 2004 | Details |
A28336 | 15605308 | Semin Liver Dis | Hepatitis C and nonalcoholic fatty liver disease. | 2004 | Details |
A28337 | 15605305 | Semin Liver Dis | Effects of weight loss surgeries on liver disease. | 2004 | Details |
A28339 | 15598336 | Pediatr Transplant | Non-alcoholic steatohepatitis in children. | 2004 | Details |
A28341 | 15582127 | J Hepatol | Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. | 2004 | Details |
A28344 | 15566509 | Liver Int | Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients. | 2004 | Details |
A28345 | 15565570 | Hepatology | Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. | 2004 | Details |
A28349 | 15544735 | Gastroenterol Hepatol | [Study of patients referred for elevated ferritin levels and/or transferrin saturation: significance of non-alcoholic fatty liver disease]. | 2004 | Details |
A28357 | 15505593 | Ann Hepatol | Nonalcoholic fatty liver disease. | 2005 | Details |
A28358 | 15505132 | Arch Intern Med | Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. | 2004 | Details |
A28362 | 15489564 | Eur J Gastroenterol Hepatol | Non-alcoholic steatohepatitis. | 2004 | Details |
A28364 | 15464659 | Clin Liver Dis | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2004 | Details |
A28369 | 15448093 | Diabetes | Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. | 2004 | Details |
A28370 | 15385714 | Korean J Hepatol | [The prevalence of metabolic syndrome in patients with nonalcoholic fatty liver disease]. | 2004 | Details |
A28375 | 15336441 | J Hepatol | A novel aminosterol reverses diabetes and fatty liver disease in obese mice. | 2004 | Details |
A28377 | 15331071 | Clin Liver Dis | Pharmacologic management of nonalcoholic fatty liver disease. | 2004 | Details |
A28378 | 15331069 | Clin Liver Dis | The potential role of genes in nonalcoholic fatty liver disease. | 2004 | Details |
A28379 | 15331067 | Clin Liver Dis | Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. | 2004 | Details |
A28381 | 15331063 | Clin Liver Dis | Nonalcoholic fatty liver disease in the pediatric population. | 2004 | Details |
A28389 | 15278103 | Int J Obes Relat Metab Disord | Hepatic steatosis in obese Chinese children. | 2004 | Details |
A28395 | 15239102 | Hepatology | Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. | 2004 | Details |
A28396 | 15239085 | Hepatology | Beyond insulin resistance in NASH: TNF-alpha or adiponectin? | 2004 | Details |
A28399 | 15225167 | Aliment Pharmacol Ther | Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. | 2004 | Details |
A28400 | 15210498 | Arch Dis Child | Fatty liver disease in children. | 2004 | Details |
A28401 | 15209628 | J Gastroenterol Hepatol | Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease. | 2004 | Details |
A28405 | 15194655 | Gut | Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. | 2004 | Details |
A28406 | 15191202 | Dig Liver Dis | Searching for coeliac disease in patients with non-alcoholic fatty liver disease. | 2004 | Details |
A28408 | 15166226 | J Biol Chem | Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. | 2004 | Details |
A28409 | 15151626 | J Gastroenterol Hepatol | Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. | 2004 | Details |
A28410 | 15144045 | Rev Invest Clin | [An update on non-alcoholic fatty liver disease]. | 2004 | Details |
A28417 | 15104027 | J Insur Med | Nonalcoholic fatty liver disease (NAFLD): a comprehensive review. | 2004 | Details |
A28420 | 15085483 | Semin Liver Dis | Nonalcoholic steatohepatitis. | 2004 | Details |
A28421 | 15084161 | Am J Transplant | Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. | 2004 | Details |
A28423 | 15057893 | Hepatology | Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. | 2004 | Details |
A28426 | 15046183 | Dig Liver Dis | Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? | 2004 | Details |
A28429 | 15017611 | Clin Gastroenterol Hepatol | Nonalcoholic fatty liver disease in patients with type 2 diabetes. | 2004 | Details |
A28431 | 15012772 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock? | 2004 | Details |
A28435 | 14969505 | Obes Rev | Hepatic steatosis in obese patients: clinical aspects and prognostic significance. | 2004 | Details |
A28438 | 14762795 | Gastroenterology | Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. | 2004 | Details |
A28439 | 14752836 | Hepatology | Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. | 2004 | Details |
A28444 | 14705824 | Dig Dis Sci | Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. | 2003 | Details |
A28446 | 14685853 | Virchows Arch | Non-alcoholic fatty liver disease: an emerging pathological spectrum. | 2003 | Details |
A28448 | 14672613 | J Hepatol | The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. | 2004 | Details |
A28449 | 14671152 | J Clin Endocrinol Metab | Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. | 2003 | Details |
A28450 | 14642613 | J Hepatol | Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. | 2003 | Details |
A28452 | 14620622 | Dig Liver Dis | Impaired insulin-mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of insulin resistance. | 2003 | Details |
A28454 | 14610526 | Int J Obes Relat Metab Disord | Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients. | 2004 | Details |
A28455 | 14609346 | Drugs | Advances in the understanding and treatment of nonalcoholic fatty liver disease. | 2003 | Details |
A28457 | 14599934 | Hepatobiliary Pancreat Dis Int | Non-alcoholic fatty liver disease: the problems we are facing. | 2003 | Details |
A28458 | 14598660 | Ryumachi | [Systemic lupus erythematosus with steroid induced non-alcoholic steatohepatitis: a case report]. | 2003 | Details |
A28459 | 14585234 | Curr Treat Options Gastroenterol | Treatment of Nonalcoholic Fatty Liver Disease. | 2003 | Details |
A28461 | 14571229 | J Pediatr | Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. | 2003 | Details |
A28462 | 14564188 | J Clin Gastroenterol | Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease? | 2004 | Details |
A28463 | 14561231 | BMC Gastroenterol | Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. | 2003 | Details |
A28477 | 12768215 | Rev Gastroenterol Peru | [Non-alcoholic fatty liver]. | 2003 | Details |
A28478 | 12749246 | Hepatogastroenterology | Insulin resistance in patients with steatohepatitis. | 2003 | Details |
A28480 | 12734049 | Curr Gastroenterol Rep | Nonalcoholic steatohepatitis in children. | 2003 | Details |
A28485 | 12677986 | Ugeskr Laeger | [Nonalcoholic steatohepatitis. Three case reports]. | 2003 | Details |
A28486 | 12677985 | Ugeskr Laeger | [Nonalcoholic steatohepatitis--a "new" hepatic disease]. | 2003 | Details |
A28487 | 12668987 | Hepatology | Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. | 2003 | Details |
A28489 | 12643175 | Curr Diab Rep | Hepatic steatosis and type 2 diabetes mellitus. | 2002 | Details |
A28493 | 12542595 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? | 2003 | Details |
A28494 | 12540784 | Hepatology | Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. | 2003 | Details |
A28496 | 12530944 | Curr Gastroenterol Rep | Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis. | 2003 | Details |
A28497 | 12516196 | Clin Liver Dis | The liver in obesity and type 2 diabetes mellitus. | 2002 | Details |
A28499 | 12506331 | Swiss Med Wkly | Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations. | 2002 | Details |
A28502 | 12468416 | Best Pract Res Clin Endocrinol Metab | Obesity and liver disease. | 2002 | Details |
A28506 | 12420034 | Can J Gastroenterol | Motion - all patients with NASH need to have a liver biopsy: arguments for the motion. | 2002 | Details |
A28510 | 12406443 | Best Pract Res Clin Gastroenterol | Steatohepatitis in children. | 2002 | Details |
A28512 | 12406441 | Best Pract Res Clin Gastroenterol | The metabolic abnormalities associated with non-alcoholic fatty liver disease. | 2002 | Details |
A28514 | 12406439 | Best Pract Res Clin Gastroenterol | Animal models of steatohepatitis. | 2002 | Details |
A28515 | 12406438 | Best Pract Res Clin Gastroenterol | Pathogenesis of steatohepatitis. | 2002 | Details |
A28518 | 12352254 | Curr Opin Pediatr | Nonalcoholic fatty liver disease (NAFLD) in children. | 2002 | Details |
A28519 | 12296456 | Nutr Rev | Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. | 2002 | Details |
A28520 | 12214335 | Rev Gastroenterol Mex | [Non-alcoholic steatohepatitis]. | 2002 | Details |
A28525 | 12122975 | Rev Gastroenterol Disord | Nonalcoholic fatty liver disease. | 2002 | Details |
A28530 | 12000605 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease. | 2002 | Details |
A28531 | 11990393 | Dig Liver Dis | Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. | 2002 | Details |
A28532 | 11944631 | Semin Gastrointest Dis | Fat and the liver--a molecular overview. | 2002 | Details |
A28534 | 22822324 | Ochsner J | Nonalcoholic Fatty liver disease from the perspective of an internist. | 2002 | Details |
A28541 | 11768567 | Scand J Gastroenterol Suppl | Non-alcoholic steatohepatitis: clinical significance and pathogenesis. | 2001 | Details |
A28542 | 11756758 | Adv Anat Pathol | The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. | 2002 | Details |
A28546 | 11603045 | Tidsskr Nor Laegeforen | [Non-alcoholic steatohepatitis]. | 2001 | Details |
A28550 | 11567710 | Lancet | Metformin in non-alcoholic steatohepatitis. | 2001 | Details |
A28552 | 11475019 | Ned Tijdschr Geneeskd | [Abdominal obesity: metabolic complications and consequences for the liver]. | 2001 | Details |
A28553 | 11473047 | Diabetes | Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. | 2001 | Details |
A28555 | 11438497 | Gastroenterology | Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. | 2001 | Details |
A28557 | 11432515 | Dig Liver Dis | Insulin resistance in non-alcoholic steatohepatitis. | 2001 | Details |
A28567 | 10804323 | Diabetes Metab | Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. | 2000 | Details |
A28733 | 35085894 | Biochem Biophys Res Commun | Liver cyclophilin D deficiency inhibits the progression of early NASH by ameliorating steatosis and inflammation. | 2022 | Details |
A28740 | 35076966 | Hepatology | Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery. | 2022 | Details |
A28763 | 35039610 | Lab Invest | High-fat diet-induced nonalcoholic steatohepatitis is accelerated by low carnitine and impaired glucose tolerance in novel murine models. | 2022 | Details |
A28801 | 34986326 | Cell Chem Biol | An antisense transcript transcribed from Irs2 locus contributes to the pathogenesis of hepatic steatosis in insulin resistance. | 2022 | Details |